Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Taipei, July 20 (CNA) Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Argentine garlic, Ukrainian sorghum among items seized at border
03/19/2024 02:54 PM - Business
Taiwan shares close down 0.11%
03/19/2024 02:15 PM - Politics
Vice President-elect Hsiao in the Czech Republic: MOFA
03/19/2024 02:08 PM - Society
Taiwan Railway to add 26 train services for Dajia Mazu Pilgrimage
03/19/2024 12:26 PM - Society
Taiwan headline news
03/19/2024 11:33 AM